Cannabinoid Receptor Antagonists and the Metabolic Syndrome: Novel Promising Therapeutical Approaches

Author(s): C. Cervino, R. Pasquali, U. Pagotto.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 7 , Issue 1 , 2007

Become EABM
Become Reviewer


Recent findings in animals and in humans have shown that cannabinoid type 1 receptor antagonists are suitable to become the most promising validated class of drugs to tackle obesity and related disorders. This mini-review will provide a concise and updated revision of the state of art on this topic.

Keywords: Endocannabinoid, cannabinoid type 1 receptor, cannabinoid type 1 receptor antagonist, rimonabant, metabolic syndrome

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [21 - 30]
Pages: 10
DOI: 10.2174/138955707779317812

Article Metrics

PDF: 8